Oppenheimer & Co. Inc. Has $325,000 Position in UiPath, Inc. (NYSE:PATH)

Oppenheimer & Co. Inc. lessened its holdings in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 89.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,598 shares of the company's stock after selling 282,649 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in UiPath were worth $325,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of PATH. Truist Financial Corp purchased a new position in UiPath during the 4th quarter valued at about $307,000. Bank of New York Mellon Corp grew its stake in shares of UiPath by 2.8% in the 4th quarter. Bank of New York Mellon Corp now owns 2,437,756 shares of the company's stock valued at $30,984,000 after buying an additional 66,100 shares in the last quarter. Amalgamated Bank grew its stake in shares of UiPath by 3.1% in the 4th quarter. Amalgamated Bank now owns 28,148 shares of the company's stock valued at $358,000 after buying an additional 836 shares in the last quarter. Proficio Capital Partners LLC bought a new stake in shares of UiPath in the 4th quarter valued at approximately $307,000. Finally, SVB Wealth LLC bought a new stake in shares of UiPath in the 4th quarter valued at approximately $385,000. Hedge funds and other institutional investors own 62.50% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Morgan Stanley boosted their price target on UiPath from $12.00 to $15.00 and gave the company an "equal weight" rating in a research note on Monday, June 2nd. Scotiabank boosted their price target on UiPath from $12.00 to $13.00 and gave the company a "sector perform" rating in a research note on Friday, May 30th. Evercore ISI boosted their price target on UiPath from $11.00 to $15.00 and gave the company an "in-line" rating in a research note on Friday, May 30th. DA Davidson raised UiPath to a "hold" rating in a research note on Monday, June 9th. Finally, Needham & Company LLC reissued a "hold" rating on shares of UiPath in a research note on Friday, May 30th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, UiPath currently has an average rating of "Hold" and a consensus price target of $13.83.

Insider Buying and Selling

In other news, CEO Daniel Dines sold 45,000 shares of the company's stock in a transaction that occurred on Wednesday, July 2nd. The stock was sold at an average price of $12.54, for a total transaction of $564,300.00. Following the completion of the transaction, the chief executive officer directly owned 5,463,376 shares in the company, valued at $68,510,735.04. The trade was a 0.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Ashim Gupta sold 98,795 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $12.01, for a total value of $1,186,527.95. Following the transaction, the chief financial officer owned 987,322 shares of the company's stock, valued at approximately $11,857,737.22. This trade represents a 9.10% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 380,117 shares of company stock valued at $4,726,694. Corporate insiders own 23.19% of the company's stock.

UiPath Stock Up 3.3%

Shares of PATH stock traded up $0.42 during trading hours on Friday, reaching $13.27. 6,853,764 shares of the company's stock were exchanged, compared to its average volume of 10,429,996. UiPath, Inc. has a fifty-two week low of $9.38 and a fifty-two week high of $15.93. The stock has a market capitalization of $7.10 billion, a P/E ratio of -110.57, a P/E/G ratio of 17.41 and a beta of 1.04. The business has a fifty day moving average price of $12.60 and a 200-day moving average price of $12.47.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. UiPath had a negative return on equity of 3.05% and a negative net margin of 4.65%. The company had revenue of $356.62 million during the quarter, compared to analyst estimates of $332.17 million. During the same period in the previous year, the company earned $0.13 earnings per share. The company's quarterly revenue was up 6.4% compared to the same quarter last year. As a group, research analysts expect that UiPath, Inc. will post -0.17 EPS for the current fiscal year.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.